Cargando…

Comparison of reversal and adverse effects of sugammadex and combination of — Anticholinergic-Anticholinesterase agents in pediatric patients

BACKGROUND: We aimed to compare clinical effects of sugammadex versus combination of anticholinergic-anticholinesterase agents for reversing of nondepolarizing neuromuscular block in pediatric patients. MATERIALS AND METHODS: A total of 60 pediatric patients whom should be performed general anesthes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Özgün, Çiğdem, Çakan, Türkay, Baltacı, Bülent, Başar, Hülya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235098/ https://www.ncbi.nlm.nih.gov/pubmed/25422663

Ejemplares similares

Comparison of analgesic efficacy of intravenous Paracetamol and intravenous dexketoprofen trometamol in multimodal analgesia after hysterectomy
por: Ünal, Çiğdem, et al.
Publicado: (2013)

Comparison of hemodynamic and metabolic stress responses caused by endotracheal tube and Proseal laryngeal mask airway in laparoscopic cholecystectomy
por: Güleç, Handan, et al.
Publicado: (2012)

Detection method of intraoperative awareness: a randomized comparative study
por: BEKTAŞ, Meltem, et al.
Publicado: (2022)

Reversal by Sugammadex
por: Bajaj, Pramila
Publicado: (2009)

A Rare Cause of Epistaxis: Nasopharyngeal Leech Infestation
por: Bektas, Meltem, et al.
Publicado: (2023)

Cardiovascular adverse effects of sugammadex
por: Kapoor, Mukul Chandra
Publicado: (2020)

Sugammadex in pediatric patients
por: Choi, Jae Moon, et al.
Publicado: (2022)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Results of genicular nerve ablation by radiofrequency in osteoarthritis-related chronic refractory knee pain
por: KONYA*, Zafer Yasin, et al.
Publicado: (2020)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017)

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019)

Adverse Effects of Sugammadex on the Cardiovascular System
por: Kadiyala, Mamatha, et al.
Publicado: (2023)

Sugammadex, a Neuromuscular Blockade Reversal Agent, Causes Neuronal Apoptosis in Primary Cultures
por: Palanca, José M., et al.
Publicado: (2013)

Rationale for the Use of Anticholinergic Agents in Overactive Bladder With Regard to Central Nervous System and Cardiovascular System Side Effects
por: Çetinel, Bülent, et al.
Publicado: (2013)

Sugammadex is effective in reversing rocuronium in the presence of antibiotics
por: Hudson, Mark E, et al.
Publicado: (2014)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Effect of sevoflurane anaesthesia on nasal mask in endoscopic retrograde cholangiopancreatography: is it a preferred alternative?
por: BALTACI, Bülent, et al.
Publicado: (2020)

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2015)

Synthesis of Bistetrahydroquinolines as Potential Anticholinesterasic Agents by Double Diels-Alder Reactions
por: Duarte, Yorley, et al.
Publicado: (2013)

Adverse events of sugammadex that occurred in a Korean population
por: Han, Woong, et al.
Publicado: (2022)

Anticholinergic Agents Can Induce Oromandibular Dyskinesia
por: Shin, Hee-Young, et al.
Publicado: (2009)

The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex
por: Oh, Tak Kyu, et al.
Publicado: (2019)

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
por: Ledowski, Thomas, et al.
Publicado: (2013)

Cardiac arrest after administration of sugammadex as neuromuscular blockade reversal agent and full recovery from anesthesia
por: Samara, Evangelia, et al.
Publicado: (2020)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
por: Aouad, Marie T., et al.
Publicado: (2017)

Anticholinesterase Toxicity and Oxidative Stress
por: Milatovic, Dejan, et al.
Publicado: (2006)

The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review
por: Liu, Guangyu, et al.
Publicado: (2017)

Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis
por: Won, Young Ju, et al.
Publicado: (2016)

Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex
por: Brull, Sorin J, et al.
Publicado: (2009)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron, Michele, et al.
Publicado: (2017)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
por: Cheong, Soon Ho, et al.
Publicado: (2015)

Neuronal Effects of Sugammadex in combination with Rocuronium or Vecuronium
por: Aldasoro, Martin, et al.
Publicado: (2017)

Clinical efficacy and safety of anticholinergic therapies in pediatric patients
por: Goldstein, Stanley
Publicado: (2019)

The Role of Dexmedetomidine in Pediatric Patients Presenting with an Anticholinergic Toxidrome
por: Zekhtser, Mitchell, et al.
Publicado: (2021)

Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents
por: Qin, Jiangke, et al.
Publicado: (2013)

Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
por: Galdeano, Carles, et al.
Publicado: (2018)

Design, Synthesis, and Structure–Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer’s Disease
por: Sağlık, Begüm Nurpelin, et al.
Publicado: (2020)

4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer’s Disease
por: Komatović, Katarina, et al.
Publicado: (2022)

Anticholinesterase and Serotoninergic Evaluation of Benzimidazole–Carboxamides as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease
por: Belinskaia, Daria A., et al.
Publicado: (2023)

Desmopressin in combination with anticholinergic agents in the treatment of nocturnal enuresis: a systematic review and meta-analysis
por: Cai, Tong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0rub2nbn7m7aff118a9j6060ii